THE TREND
(Boursier.com) — Like the second part of yesterday’s session, the CAC40 is hesitant with the caution of investors preceding the announcements of the European Central Bank and while the political crisis in Italy is gaining momentum. magnitude. The CAC40 is stable at the end of the morning around 6,190 points but the ranking is driven by the acceleration of the publications of half-year results or turnover.
The Milan Stock Exchange is currently down 2% after the resignation of Mario Draghi following the breakup of his coalition government. The Italian 10-year rates are logically tending again to 3.62% while the ECB is due to detail this Thursday its anti-fragmentation mechanism supposed to fight against an excessive spread in the refinancing rates of the states of the euro zone.
ECB President Christine Lagarde had indicated that key rates would be raised by 0.25 basis points, and this remains the preferred option for the markets, but recent information indicates that the institution’s governors will discuss a possible increase of half a point in the face of the acceleration of inflation… To be continued later.
RISING VALUES
* Publicis (+4.30% to 49.2 euros): On the sidelines of the publication of net income Group share for the 1st half of the year amounting to 537 million euros against 414 million euros the previous year, Publicis announces that it is anticipating now organic growth for the whole of 2022 between +6 and +7% versus +4 to +5% previously, an operating margin rate of between 17.5% and 18%, versus around 17.5% previouslyand free cash flow before working capital of at least 1.5 billion euros, compared to approximately 1.4 billion euros previously.
* Ipsos (+3% to 48 euros): Net income, Group share, amounted to 85 million euros (72 ME in the 1st half of 2021), up 18.8%. Adjusted net income, Group share, which is the relevant and constant indicator used to measure performance, is also up to 98 ME (81 ME last year at the same period), up 19. 8%.
* Mersen (+2% to 31.5 euros) raised its objectives for 2022. The Group now expects: organic growth of between 8% and 10% (3% to 6% previously) with a current operating margin of around 10.5% of turnover (around 10% previously).
* Airbus gained 0.6% to 105.3 euros. easyJet has confirmed a firm order for 56 A320neo Family aircraft. This order is part of the renewal of the easyJet fleet, the improvement of costs and the sustainability of the company. The agreement includes the conversion of an order of 18 A320neos to the larger A321neo.
* Orpea rose 3% to 23.5 euros. Revenue for the 1st half of 2022 amounted to €2,312 million, up +11.7%, of which +6.4% organically. Turnover in the second quarter amounted to 1,192 ME, representing growth of +14.4% vs. 2021, of which +7.7% organically.
* Sartorius Stedim Biotech gains 7% to 364 euros. Current LEBITDA increased by 24.5% to €607 million during the first half. The corresponding margin reached 35.2% (same period last year: 36.1%). The net current result per share was 4.40 euros (same period of the previous financial year: 3.49 euros).
* SergeFerrari Group (+4%) again raised its 2022 revenue forecast to 335 ME against a previous range of 310 to 325 ME.
FALLING VALUES
* Thales yields 0.8% to 121.2 euros. On the strength of its consolidated net income, Group share, which amounts to 566 ME, up 31% compared to the first half of 2021, Thales is revising its 2022 objectives with now a book-to-bill ratio “significantly higher than 1” and organic revenue growth between +3.5% and +5.5%. The EBIT margin target is unchanged between 10.8% and 11.1%. Expectations around the half-year accounts of Thales were however very high…
* Largest drop in the CAC40, TotalEnergies lost 2.5% to 48 euros in the wake of oil prices. WTI is down more than 4% around $95.
* Valneva fell 6% to 9.88 euros. The European Commission has approved an amendment to the advance purchase agreement signed in November 2021 for the inactivated whole-virus vaccine against COVID-19 from Valneva, VLA2001. Under this amendment, participating Member States will only order 1.25 million doses of VLA2001 in 2022 and will have the option of ordering and having the same quantity delivered later this year. This amendment results from discussions following the European Commission’s notice of intent to terminate the initial agreement to purchase VLA2001 in 2022 with optional doses in 2023.
* SEB (-10.5% to 83.5 euros) lowered its assumption for growth in sales and operating profit from activity in 2022. of activity between 8% and 8.5% over the year. These new assumptions include additional costs (materials, components, freight, currencies) now estimated at 300 ME (200 ME initially).
* Navya fell 33% to 0.59 euros. The company has entered into a financing agreement for a total nominal amount of 36 ME with the Negma Group, an investment company based in Dubai in the United Arab Emirates. he financing will be carried out in the form of bonds convertible into new shares (“OCA”) to which stock subscription warrants (“BSA”) are attached.